Related Experiment Video

Updated: Jul 27, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

Live attenuated HIV vaccines: a proposal for further research and development

J Mills1, R Desrosiers, E Rud

  • 1Macfarlane Burnet Centre for Medical Research, Fairfield (Melbourne), Victoria, Australia. mills@burnet.edu.au

AIDS Research and Human Retroviruses
|October 29, 2000
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Related Experiment Videos

Last Updated: Jul 27, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Articles linked to this work by shared authors, journal, and citation graph.

Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2016

Management of agricultural soils for greenhouse gas mitigation: Learning from a case study in NE Spain.

Journal of environmental management·2016

Tomographic imaging of nonsymmetric multicomponent tailored supersonic flows from structured gas nozzles.

Applied optics·2015

Psychometric evaluation of the Indonesian version of the Impact of Event Scale-Revised.

Journal of psychiatric and mental health nursing·2015

Human rights of the mentally ill in Indonesia.

International nursing review·2014

Learning from the QUEST multicentre feasibility randomization trials in breast reconstruction after mastectomy.

The British journal of surgery·2014

Efficacy and Safety of Albuvirtide Plus Dolutegravir or Dolutegravir/Lamivudine in Hospitalized People with Advanced AIDS: A Retrospective Real-World Study.

AIDS research and human retroviruses·2026

Genomic Characterization of Two Novel HIV-1 CRF01_AE/CRF07_BC Unique Recombinant Forms in Shenzhen, China.

AIDS research and human retroviruses·2026

Post-Traumatic Stress Symptoms Related to the COVID-19 Pandemic in Persons Living and Aging with HIV.

AIDS research and human retroviruses·2026

Sequence Notes: Identification of a Novel HIV-1 Circulating Recombinant Form (CRF200_0755) in a Southern Border Region of Yunnan, China.

AIDS research and human retroviruses·2026

Fluctuating Immune Reconstitution and Delayed HIV-1 DNA Decline in People Living with HIV with Low CD4 on Bictegravir-Based Therapy.

AIDS research and human retroviruses·2026

Identification of a Complex HIV-1 Circulating Recombinant Form (CRF203_cpx) Originating from Three Main Circulating Recombinant Forms in China.

AIDS research and human retroviruses·2026

Impact of light on inner workings of neuronal functions.

International review of neurobiology·2026

Next-generation delivery systems for coenzyme Q10: trends in nanovesicles, penetration enhancers, and bioactivity optimization.

Journal of liposome research·2026

Insights into Genome Ejection by a Therapeutic phiKMV-like Bacteriophage.

Journal of molecular biology·2026

Strategic manufacturing and versatile applications to expand the mRNA therapeutic frontier.

Drug discovery today·2026

Identification of a novel likely pathogenic MT-TS2 variant in a patient with mitochondrial myopathy, retinitis pigmentosa and sensorineural hearing loss.

Neuromuscular disorders : NMD·2026

Individualized Interactomes From Pulmonary Arterial Hypertension Cell Biopsies Inform Pharmacotherapeutic Response.

JACC. Basic to translational science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us